Australian shares are expected to slip into the red at market open Friday as investors follow losses from Wall Street overnight.
The Nasdaq and the S&P 500 shed 0.2% each on Thursday, with Tesla driving the losses following a drop in vehicle deliveries for 2024. The Dow Jones Industrial Average was down 0.4%.
In macroeconomic news, the commodity price index rose 0.6% month over month in December 2024 in special drawing rights (SDR) terms, following a revised 1.3% increase in the prior month, preliminary data from the Reserve Bank of Australia showed Thursday.
In corporate news, Imugene (ASX:IMU) dosed the first Australian patient in the Phase 1b clinical trial of its azer-cel therapy, which is being assessed as a potential treatment for non-Hodgkin's lymphoma.
Arcadium Lithium (ASX:LTM) and Livent entered into a second supplemental indenture on Jan. 1.
UBS Securities Australia ceased to be a substantial holder in SG Fleet Group (ASX:SGF).
Australia's benchmark index rose 0.5%, or 42.10 points, Thursday to close at 8,201.20.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。